Kynam Capital Management, LP Caribou Biosciences, Inc. Put Options Transaction History
Kynam Capital Management, LP
- $1.18 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CRBU
# of Institutions
124Shares Held
39.9MCall Options Held
42.2KPut Options Held
93.2K-
Black Rock Inc. New York, NY6.95MShares$14.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.23MShares$8.58 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.22MShares$6.53 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$3.67 Million0.01% of portfolio
-
Abrdn PLC1.39MShares$2.82 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $124M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...